Pharmacogenomics: road to anticancer therapeutics nirvana? - Wikidata - awgldk - TriplyDB

Pharmacogenomics: road to anticancer therapeutics nirvana?

Pharmacogenomics: road to anticancer therapeutics nirvana?

http://www.wikidata.org/entity/Q35551155

about

Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer Impact of proteomics on bladder cancer research.Drug development in oncology: classical cytotoxics and molecularly targeted agents.Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens EGFR-targeted therapies in lung cancer: predictors of response and toxicity A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme.Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients.

P2860

Q24629139-4F459312-C4D2-43BD-846D-54F2E7DCC5E4 Q34274096-211FE260-CBB6-4E00-84C3-B4CFDCD68A57 Q35785226-D5593036-4640-43D4-9943-B772C5477730 Q35827606-E868A3F4-265D-4B17-BFB5-C324DCCF731D Q35887458-25A2AEFA-D8D5-4171-BBA3-8EE4A5236A07 Q37160173-2F291EB2-D088-4B2F-839A-A160929FC212 Q37451156-09DDD799-076A-4D14-9370-A5A47EEE1F09 Q37567702-ABB2C193-6B50-48EF-B833-0A4CDE002D2D Q50039487-B24BB2AE-59BB-4759-A382-97E6A614D58E Q53253992-3620AC25-051C-4948-B5E9-A058EA924ADD

P2860

Pharmacogenomics: road to anticancer therapeutics nirvana?

http://www.wikidata.org/entity/Q35551155

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pharmacogenomics: road to anticancer therapeutics nirvana?

@ast

Pharmacogenomics: road to anticancer therapeutics nirvana?

@en

type

label

Pharmacogenomics: road to anticancer therapeutics nirvana?

@ast

Pharmacogenomics: road to anticancer therapeutics nirvana?

@en

prefLabel

Pharmacogenomics: road to anticancer therapeutics nirvana?

@ast

Pharmacogenomics: road to anticancer therapeutics nirvana?

@en

P1433

Q35551155-9630A782-3FDD-4C58-B51F-D463B5D19834

P1476

Q35551155-57267C30-9808-471D-81AB-BA7562841E6E

P2093

Q35551155-230935F9-45BC-4723-9C37-B6FF6F3E49AC

Q35551155-79E0D9C3-3DC7-42EF-8B69-D812E8155794

P2860

Q35551155-2C31BA8A-D2F8-41E6-89E1-335CE5D118CC

Q35551155-2DD15DC2-16C0-4924-99E8-F73FE30154C4

Q35551155-34CB1EE9-C50E-4CF0-AE79-DA7C28999064

Q35551155-4136462E-A7F6-41FE-8DBD-13AC5C77C8CB

Q35551155-4C9DBAF5-76C1-4ACE-A9B9-33DA5D8B1B9B

Q35551155-5153399B-EC36-494E-ACB5-534BF9F0227D

Q35551155-51693ED6-8E31-4C9A-970D-911A4B20B947

Q35551155-5CE1C462-06D6-4BF7-A888-6352CA41D71E

Q35551155-71E6BEF2-E311-4870-A806-EF4E671F60A4

Q35551155-76822E82-D558-4F19-BC94-D90C28012390

P2888

Q35551155-A87A8C99-DCD8-4377-BD7E-436778F2B261

P304

Q35551155-3397BB35-8B8F-4D6A-9CC6-9CB24A37801B

P31

Q35551155-E71A66E5-7D35-472C-8098-8197A6ED5297

P356

Q35551155-8E2C0A42-3B55-4A56-821F-01F3EC720722

P407

Q35551155-02B55157-A842-4A84-B8CB-20737A835CB8

P433

Q35551155-0F0D1C73-3FD2-45C8-B270-30BA08E9B91C

P478

Q35551155-63BFA1EB-A3AF-4658-A6A1-C4C0D5381B76

P50

Q35551155-DBA8AF50-6FA5-4395-A536-9091208616AF

P577

Q35551155-ADF89388-9E33-4E4E-910C-9961541F7BDD

P5875

Q35551155-DC71FE3C-6110-4315-AF37-E4AC5BC042A5

P698

Q35551155-F30CFABB-1145-4E29-AE70-C56BD76EF8BB

P921

Q35551155-27114C6B-45EF-4A65-91B4-C0FCCFD1F73A

P356

P1433

P1476

Pharmacogenomics: road to anticancer therapeutics nirvana?

@en

P2093

Apurva A Desai

http://www.w3.org/2001/XMLSchema#string

Federico Innocenti

http://www.w3.org/2001/XMLSchema#string

P2860

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Clinical trial designs for cytostatic agents: are new approaches needed?

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

Epidermal growth factor-related peptides and their receptors in human malignancies

Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase

Irinotecan in the treatment of colorectal cancer: clinical overview.

Molecular genetic basis of Gilbert's syndrome.

Development of target-based antineoplastic agents.

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.

P2888

P304

6621-6628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206958

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9064505

http://www.w3.org/2001/XMLSchema#string

P698

14528287

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics